Cochlear Limited

Company Profile

Cochlear Limited had its IPO on under the ticker symbol CHEOF.

The company operates in the Healthcare sector and Medical Devices industry. Cochlear Limited has a staff strength of 4,500 employees.

Stock update

Shares of Cochlear Limited opened at $153.88 at the start of the last trading session i.e. 2023-03-21.

The stocks traded within a range of $153.88 - $153.88, and closed at $153.88.

This is a 0% increase from the previous day's closing price.

A total volume of 0 shares were traded at the close of the day’s session.

In the last one week, shares of Cochlear Limited have increased by +2.49%.

Cochlear Limited's Key Ratios

Cochlear Limited has a market cap of $10.12 billion, indicating a price to book ratio of 8.0768 and a price to sales ratio of 5.6886.

In the last 12-months Cochlear Limited’s revenue was $1.71 billion with a gross profit of $1.24 billion and an EBITDA of $394.30 million. The EBITDA ratio measures Cochlear Limited's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Cochlear Limited’s operating margin was 20.8% while its return on assets stood at 9.09% with a return of equity of 15.18%.

In Q2, Cochlear Limited’s quarterly earnings growth was a negative -16.4% while revenue growth was a positive 7.9%.

Cochlear Limited’s PE and PEG Ratio

Forward PE

45.6621

Trailing PE

58.5078

PEG

0

Its diluted EPS in the last 12-months stands at $2.63 per share while it has a forward price to earnings multiple of 45.6621 and a PEG multiple of 0. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Cochlear Limited’s profitability.

Cochlear Limited stock is trading at a EV to sales ratio of 5.489 and a EV to EBITDA ratio of 19.0313. Its price to sales ratio in the trailing 12-months stood at 5.6886.

Cochlear Limited stock pays annual dividends of $1.45 per share, indicating a yield of 1.47% and a payout ratio of 75.47%.

Balance sheet and cash flow metrics

Total Assets

$2.47 billion

Total Liabilities

$527.60 million

Operating Cash Flow

$-29250000.00

Capital Expenditure

$11.80 million

Dividend Payout Ratio

75.47%

Cochlear Limited ended 2023 with $2.47 billion in total assets and $0 in total liabilities. Its intangible assets were valued at $2.47 billion while shareholder equity stood at $1.69 billion.

Cochlear Limited ended 2023 with $33.00 million in deferred long-term liabilities, $527.60 million in other current liabilities, 1276600000.00 in common stock, $455.30 million in retained earnings and $257.10 million in goodwill. Its cash balance stood at $629.30 million and cash and short-term investments were $0. The company’s total short-term debt was $0 while long-term debt stood at $0.

Cochlear Limited’s total current assets stands at $1.33 billion while long-term investments were $119.10 million and short-term investments were $0. Its net receivables were $390.40 million compared to accounts payable of $232.40 million and inventory worth $270.20 million.

In 2023, Cochlear Limited's operating cash flow was $-29250000.00 while its capital expenditure stood at $11.80 million.

Comparatively, Cochlear Limited paid $0.75 in dividends in 2023.

Other key metrics

Current Trading Price

$153.88

52-Week High

$171.2837

52-Week Low

$118.425

Analyst Target Price

$

Cochlear Limited stock is currently trading at $153.88 per share. It touched a 52-week high of $171.2837 and a 52-week low of $171.2837. Analysts tracking the stock have a 12-month average target price of $.

Its 50-day moving average was $146.71 and 200-day moving average was $151.42 The short ratio stood at 0 indicating a short percent outstanding of 0%.

Around 49.4% of the company’s stock are held by insiders while 4497.4% are held by institutions.